Axis Mutual FundIndex Funds - Equity Funds1.7 years
The scheme seeks to provide returns before expenses that correspond to the Nifty500 Momentum 50 TRI subject to tracking errors.
Buying brief
Evidence on this desk, framed as a purchase checklist - not SEBI-registered advice.
As of 30 Oct 2026
Stance
Fit for a long SIP
Evidence supports keeping this on a shortlist for a multi-year equity SIP.
In three lines
Fits if · No material deterioration, cost shock, or persistent category underperformance in the current evidence set.
Buy checklist
History depth
Fail
1.7 years - thin for judging consistency.
Engine status
Pass
Evidence supports keeping this on a shortlist for a multi-year equity SIP.
Expense ratio
Pass
0.58% TER (Direct). Lower cost compounds on long SIPs.
Drawdown vs peers
Pass
Peak-to-trough -17.0%. Ask whether you can hold through a similar fall.
Vs category
n/a
Category relative read still thin.
Manager tenure
Watch
Nandik Mallik · 0.7 years on the scheme.
Exit load
n/a
No exit-load summary on file.
Tax / wrapper
Pass
Direct Growth, no ELSS lock flagged. Equity LTCG rules still apply after one year - not tax advice.
Portfolio concentration
Pass
Top 10 holdings ≈ 45.8% of the portfolio.
Evidence supports a shortlist - confirm with peers before you buy elsewhere.
Behaviour and wrappers - the usual India MF failure modes - not a buy instruction.
Drawdown rehearsal
This scheme’s worst fall on file is about 17%. Before you SIP, ask whether you would keep contributing through a similar drop - pausing on fear is the usual India MF failure mode.
SIP discipline
If you start a SIP here, diary a 90-day check and an annual review - don’t react to every NAV print.
NAV
Path not in current snapshots
n/a
Trailing CAGR and simulated monthly SIP XIRR from daily NAV. Category comparison uses the median of comparable share classes in the peer set.
Trailing CAGR
Point-to-point, calendar-day annualized
SIP XIRR
Equal monthly instalments to latest NAV
Peak to trough from a running NAV high, with the path and recovery episodes.
Drawdown
Path not in current snapshots
n/a
26 Jun 2025 – 12 Aug 2026
Trough 23 Mar 2026 · recovered in 142 days
-17.0%
28 Aug 2026 – open
Trough 23 Oct 2026 · not recovered
-12.6%
24 Mar 2025 – 21 Apr 2025
Trough 7 Apr 2025 · recovered in 14 days
-8.7%
20 Feb 2025 – 24 Mar 2025
Trough 13 Mar 2025 · recovered in 11 days
-7.6%
0–100 reads of named metrics. The mean is unweighted and only uses dimensions with data.
Returns
13
Vs category
63
Consistency
41
Risk-adjusted
29
Drawdown
58
Mean
41
Quantitative engine reasons behind the buying stance. An explanation can only restate what is already here.
Buying stance
Fit for a long SIP
Evidence supports keeping this on a shortlist for a multi-year equity SIP.
Why this status
Supporting reads
No supporting reads in the current evidence set.
30 Sept 2026 · 51 holdings · top 10 are 45.8%.
Laurus Labs Ltd
Healthcare
6.2%
Multi Commodity Exchange Of India Ltd
Financial
5.9%
Shriram Transport Finance Company Ltd
Financial
4.9%
Hindalco Industries Ltd
Materials
4.9%
Adani Power Ltd
Energy & Utilities
4.5%
DECISION
Status moved from MONITOR to HEALTHY.
27 Oct 2026
Same-category peers with enough history to inspect beside this fund - including tradeoffs.
Groww Mutual Fund
Aditya Birla Sun Life Mutual Fund
Caveat: Lower trailing returns
Aditya Birla Sun Life Mutual Fund
Caveat: Deeper drawdown
Axis Mutual Fund
Caveat: Lower trailing returns
Axis Mutual Fund
Caveat: Deeper drawdown
Axis Mutual FundIndex Funds - Equity Funds1.7 years
The scheme seeks to provide returns before expenses that correspond to the Nifty500 Momentum 50 TRI subject to tracking errors.
Buying brief
Evidence on this desk, framed as a purchase checklist - not SEBI-registered advice.
As of 30 Oct 2026
Stance
Fit for a long SIP
Evidence supports keeping this on a shortlist for a multi-year equity SIP.
In three lines
Fits if · No material deterioration, cost shock, or persistent category underperformance in the current evidence set.
Buy checklist
History depth
Fail
1.7 years - thin for judging consistency.
Engine status
Pass
Evidence supports keeping this on a shortlist for a multi-year equity SIP.
Expense ratio
Pass
0.58% TER (Direct). Lower cost compounds on long SIPs.
Drawdown vs peers
Pass
Peak-to-trough -17.0%. Ask whether you can hold through a similar fall.
Vs category
n/a
Category relative read still thin.
Manager tenure
Watch
Nandik Mallik · 0.7 years on the scheme.
Exit load
n/a
No exit-load summary on file.
Tax / wrapper
Pass
Direct Growth, no ELSS lock flagged. Equity LTCG rules still apply after one year - not tax advice.
Portfolio concentration
Pass
Top 10 holdings ≈ 45.8% of the portfolio.
Evidence supports a shortlist - confirm with peers before you buy elsewhere.
Behaviour and wrappers - the usual India MF failure modes - not a buy instruction.
Drawdown rehearsal
This scheme’s worst fall on file is about 17%. Before you SIP, ask whether you would keep contributing through a similar drop - pausing on fear is the usual India MF failure mode.
SIP discipline
If you start a SIP here, diary a 90-day check and an annual review - don’t react to every NAV print.
NAV
30 Oct 2026 · -4.1% over 1Y
10.6562
Trailing CAGR and simulated monthly SIP XIRR from daily NAV. Category comparison uses the median of comparable share classes in the peer set.
Trailing CAGR
Point-to-point, calendar-day annualized
SIP XIRR
Equal monthly instalments to latest NAV
Peak to trough from a running NAV high, with the path and recovery episodes.
Drawdown
30 Oct 2026
-8.0%
26 Jun 2025 – 12 Aug 2026
Trough 23 Mar 2026 · recovered in 142 days
-17.0%
28 Aug 2026 – open
Trough 23 Oct 2026 · not recovered
-12.6%
24 Mar 2025 – 21 Apr 2025
Trough 7 Apr 2025 · recovered in 14 days
-8.7%
20 Feb 2025 – 24 Mar 2025
Trough 13 Mar 2025 · recovered in 11 days
-7.6%
0–100 reads of named metrics. The mean is unweighted and only uses dimensions with data.
Returns
13
Vs category
63
Consistency
41
Risk-adjusted
29
Drawdown
58
Mean
41
Quantitative engine reasons behind the buying stance. An explanation can only restate what is already here.
Buying stance
Fit for a long SIP
Evidence supports keeping this on a shortlist for a multi-year equity SIP.
Why this status
Supporting reads
No supporting reads in the current evidence set.
30 Sept 2026 · 51 holdings · top 10 are 45.8%.
Laurus Labs Ltd
Healthcare
6.2%
Multi Commodity Exchange Of India Ltd
Financial
5.9%
Shriram Transport Finance Company Ltd
Financial
4.9%
Hindalco Industries Ltd
Materials
4.9%
Adani Power Ltd
Energy & Utilities
4.5%
DECISION
Status moved from MONITOR to HEALTHY.
27 Oct 2026